| Tag | Content |
|---|
EnhancerAtlas ID | HS109-13114 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr2:182258050-182258550 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr2:182258503-182258524 | AAAATGAAAGTGAAAGTTAAC | - | 9.39 | | IRF2 | MA0051.1 | chr2:182258507-182258525 | TGAAAGTGAAAGTTAACA | + | 6.16 | | ZNF263 | MA0528.1 | chr2:182258434-182258455 | TCCCAAGTCTCCTCCTCCTCC | - | 6.1 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_25386 | chr2:182257770-182265552 | DND41 | | SE_61482 | chr2:182235482-182332038 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I181392 | chr2 | 182257694 | 182260727 |
|
Enhancer Sequence | AAGCTTATAC CTCCTCTACC AGTTAGAAAT ATTAAAATTA TATATTGATT CATATATATA 60
CTTGAGTCTC TTTCTGGATG CTTTATCATG GATCTCTCCC GTAATTCACT ATCACTTTTT 120
TAAATCATTA CAGTATAAAA GTACATTTTA ATATCTTAAA AGCCCCCCTC TGAACGTGGT 180
TTGTAATTCA TGAAGAGCTT TTCAATAATC AGTGCCCAAC CTACTTCCTC CCTGATGATC 240
TCATTCAGGC TCATGTCCAT AGCAACAACT TCCTATTTAT ATCTCCAGGC CACATCTCTC 300
CTGTGAGCCT TAAACTCTAT TACCCACTGG AAGGTTGAAC ATGTCTCTGT TTCAACTGGT 360
CAAAACTGAG CCCTTGAATA TTTTTCCCAA GTCTCCTCCT CCTCCAGTCT TCTTTATTCA 420
AATAAAGGGC ACTATACCAG CTAATCAGAT ACCAAAATGA AAGTGAAAGT TAACATCATT 480
GTAGCCAATC TTTACATGAG 500
|
